Visilizumab

Tidak ditemukan merek terdaftar untuk zat aktif ini.

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• AbciximabMODERAT

  Mengonsumsi Abciximab bersama Visilizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abciximab is combined with Visilizumab.

• AdalimumabMODERAT

  Mengonsumsi Adalimumab bersama Visilizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adalimumab is combined with Visilizumab.

• AdecatumumabMODERAT

  Mengonsumsi Adecatumumab bersama Visilizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adecatumumab is combined with Visilizumab.

• AfelimomabMODERAT

  Mengonsumsi Afelimomab bersama Visilizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Afelimomab is combined with Visilizumab.

• AlemtuzumabMODERAT

  Mengonsumsi Alemtuzumab bersama Visilizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Visilizumab.

• AlirocumabMODERAT

  Mengonsumsi Alirocumab bersama Visilizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alirocumab is combined with Visilizumab.

• AMG 108MODERAT

  Mengonsumsi AMG 108 bersama Visilizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when AMG 108 is combined with Visilizumab.

• AnifrolumabMODERAT

  Mengonsumsi Anifrolumab bersama Visilizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Anifrolumab is combined with Visilizumab.

• Anthrax immune globulin humanMODERAT

  Mengonsumsi Anthrax immune globulin human bersama Visilizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Visilizumab.

• Antilymphocyte immunoglobulin (horse)MODERAT

  Mengonsumsi Antilymphocyte immunoglobulin (horse) bersama Visilizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Visilizumab.